Old mice bred to develop Alzheimer's-like symptoms showed better memory and less anxiety after two months of daily CBD, with reduced brain oxidative stress as a possible mechanism.
Neuroscience researchers, those following CBD and cognitive health research, caregivers interested in emerging Alzheimer's research
What the researchers found
In SAMP8 mice (a model for Alzheimer's disease), high-dose CBD (30 mg/kg daily for two months) significantly improved learning and memory in T-maze and novel object recognition tests. CBD-treated aged mice also showed less anxiety in the elevated plus maze. Biochemical analysis revealed decreased markers of oxidative stress in the brain.
Why it matters
This adds to a small but growing body of preclinical evidence suggesting CBD may have neuroprotective properties relevant to age-related cognitive decline. The identification of reduced oxidative stress as a mechanism provides a plausible biological pathway.
The numbers in context
High dose: 30 mg/kg daily; treatment duration: 2 months; significant improvement in T-maze learning and novel object recognition at 30 mg/kg; decreased oxidative stress markers in treated mice
How the study worked
Controlled animal study using SAMP8 mice (an accelerated aging model for Alzheimer's). Mice aged 11 months received vehicle or CBD (3 or 30 mg/kg) daily via oral gavage for 2 months. Young (3-month) vehicle-treated mice served as controls. Assessed learning/memory (T-maze, novel object recognition), anxiety (elevated plus maze), activity, and strength.
What this study cannot tell us
Animal study only; results may not translate to humans. Small sample sizes typical of mouse studies. Only two doses tested. The SAMP8 model does not fully replicate human Alzheimer's pathology. No long-term follow-up after treatment ended.
How to read the evidence
Preliminary: single animal study in one mouse model, small sample, no human data.
When this study was published
2025 publication
The bigger picture
Alzheimer's treatment options remain extremely limited. While animal studies cannot predict human outcomes, identifying compounds that improve cognitive function in validated disease models is an important early step in drug development.
Questions still open
- Would these cognitive benefits persist after CBD treatment stops?
- What CBD doses in humans would correspond to the effective animal doses?
Read the original research
Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice.
PloS one, 20(8), e0296586
Citation
Goodland, Monica N; Banerjee, Subhashis; Niehoff, Michael L; Young, Benjamin J; Macarthur, Heather; Butler, Andrew A; Morley, John E; Farr, Susan A. (2025). Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice.. PloS one, 20(8), e0296586. https://doi.org/10.1371/journal.pone.0296586
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk